Synthetic aliphatic amine1, 5-Dimethylhexylamine, qee zaum hu ua DMHA lossis 2-amino-6-methylheptane, muaj cov qauv molecular tshwj xeeb. Nws muaj cov saw hlau ncaj nraim nrog yim carbon atoms thiab cov mis molecular C8H19N. Ob pawg methyl (-CH3) tau koom nrog rau thib tsib thiab yim carbon atoms, thaum thawj pawg amine (-NH2) tau koom nrog thawj carbon. Cov yam ntxwv tshwj xeeb thiab muaj peev xwm stimulant los ntawm cov khoom raug ntaus nqi rau qhov kev teeb tsa no. Cov qauv, uas zoo ib yam li cov saw hlau hydrocarbon, tau txais polarity thiab reactivity los ntawm pawg amine. Kev nkag siab txog cov qauv tshuaj lom neeg no yog qhov tseem ceeb rau cov kws tshawb fawb thiab kev lag luam ua haujlwm nrog cov khoom siv hluavtaws vim tias nws cuam tshuam li cas cov khoom siv coj mus rau ntau yam kev siv thiab cuam tshuam nrog cov kab mob lom.
Peb muab 1,5-Dimethylhexylamine CAS 543-82-8, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia thiab cov khoom lag luam.
Cov qauv tshuaj ntawm 1,5-Dimethylhexylamine cuam tshuam li cas rau nws cov tshuaj stimulant?
Cov qauv zoo sib xws rau cov neurotransmitters
Cov neurotransmitters dopamine thiab norepinephrine, uas muaj nyob rau hauv tib neeg lub cev, txawv molecularly ntawm 1,5-Dimethylhexylamine (DMHA). Vim tias cov neurotransmitters no sib koom cov qauv zoo sib xws, DMHA tuaj yeem cuam tshuam nrog tib lub thauj khoom thiab cov receptors uas cov neurotransmitters ib txwm khi rau, uas tuaj yeem cuam tshuam cov txheej txheem physiological hauv lub cev. DMHA pawg amine tseem ceeb, uas zoo ib yam li pawg amine muaj nyob hauv catecholamines zoo li norepinephrine, yog ib qho tseem ceeb ntawm cov txheej txheem. DMHA tuaj yeem cuam tshuam rau kev tso tawm neurotransmitter, rov ua dua, thiab tag nrho qhov sib npaug hauv lub hlwb vim nws cov qauv zoo sib xws. DMHA tuaj yeem ua rau muaj kev cuam tshuam xws li kev ceeb toom, lub zog, thiab ua kom pom tseeb.
Lipophilicity thiab ntshav-hlwb barrier nkag mus
Hydrocarbon chain nyob rau hauv1, 5-Dimethylhexylamine(DMHA) plays lub luag haujlwm tseem ceeb hauv nws lipophilic (fat-soluble) xwm. Cov hlab ntsha hauv hlwb (BBB), ib qho kev xaiv ntawm daim nyias nyias uas ua haujlwm ua cov lim dej tiv thaiv thiab tiv thaiv ntau yam tshuaj nkag mus rau hauv cov hlab ntsha thiab ncav cuag lub hlwb, yog kev txhawb nqa los ntawm tus yam ntxwv no. DMHA tuaj yeem nkag ncaj qha mus rau hauv nruab nrab lub paj hlwb (CNS) thiab tsim nws cov teebmeem stimulant rau cov ntaub so ntswg hlwb vim nws tuaj yeem zam cov ntshav-hlwb thaiv. Lub xub ntiag ntawm methyl pawg txuas nrog cov saw hlau txuas ntxiv ua rau cov khoom sib xyaw lipophilicity. Lub molecule tag nrho cov rog solubility yog nce los ntawm cov pab pawg ntxiv, txhim kho nws lub peev xwm los cuam tshuam nrog cov ntaub so ntswg neural. Raws li qhov tshwm sim, DMHA tuaj yeem muaj peev xwm nyob hauv lub hlwb ntev dua thiab muab kev txhawb nqa ntev ntev thiab cuam tshuam rau lub siab, lub zog, thiab kev ua kom pom tseeb. Lub hauv paus paj hlwb muaj kev cuam tshuam los ntawm DMHA vim cov yam ntxwv ntawm cov molecular.
|
|
|
Dab tsi yog cov pab pawg tseem ceeb hauv cov qauv tshuaj ntawm 1,5-Dimethylhexylamine?
Thawj pawg amine
Cov pab pawg ua haujlwm tseem ceeb tshaj plaws hauv 1,5-Dimethylhexylamine (DMHA) yog thawj amine (-NH2) txuas rau thawj cov pa roj carbon hauv cov saw hlau hydrocarbon. Cov pab pawg amine no ua lub luag haujlwm tseem ceeb hauv cov khoom siv tshuaj lom neeg thiab kev ua haujlwm lom neeg. Raws li lub cev muaj zog, pawg amine tuaj yeem dhau los ua protonated, txhais tau tias nws tuaj yeem tau txais hydrogen ion thiab tsim kom muaj txiaj ntsig zoo ammonium ion (-NH3+). Vim tias nws cov nqi zoo, DMHA tuaj yeem cuam tshuam nrog cov chaw tsis zoo ntawm cov protein, xws li cov neeg thauj khoom thiab cov khoom siv neurotransmitter. Vim tias lawv ua kom DMHA cuam tshuam rau kev ua haujlwm neurotransmitter hauv lub hlwb, cov kev sib cuam tshuam no yog qhov tseem ceeb rau nws cov teebmeem stimulant. Ntxiv mus, pawg amine muab cov molecule rau cov yam ntxwv uas yuav tsum tau, ua kom pom tias DMHA tuaj yeem ua rau cov kua qaub los tsim cov ntsev. Nws solubility hauv dej, nqus, faib, thiab cov tshuaj pharmacokinetics tuaj yeem cuam tshuam zoo heev los ntawm lub peev xwm los tsim cov ntsev. Los ntawm kev hloov pauv txoj kev sib xyaw ua ke thiab metabolized hauv lub cev, pawg amine tuaj yeem hloov pauv qhov sib xyaw pib, lub zog, thiab lub sijhawm ua haujlwm.
Alkyl saw thiab methyl ceg
Cov pa roj carbon monoxide1, 5-Dimethylhexylamine(DMHA) yog tsim los ntawm cov saw ncaj ntawm rau cov pa roj carbon atom, nrog ob pawg methyl ntxiv txuas rau ntawm txoj haujlwm thib tsib thiab yim. Vim tias lawv ua rau cov molecule hydrophobicity, los yog "dej-repellent," cov methyl pawg no tseem ceeb heev vim tias lawv cuam tshuam rau cov molecule qhov kev faib tawm thiab kev coj cwj pwm hauv cov kab mob lom. Vim tias nws yog hydrophobic, DMHA cuam tshuam nrog cov txheej txheem lipid-zoo li cell membranes-ntau yooj yim dua, ua rau nws yooj yim dua rau nws hla thiab nkag mus rau cov hlwb. Txoj kev uas cov methyl pawg thiab cov saw hlau raug teeb tsa muab cov molecule ib qho txawv peb-dimensional zoo uas kuj yuav cuam tshuam zoo npaum li cas nws haum rau qhov tshwj xeeb receptor binding qhov chaw. Vim nws cov yam ntxwv tshwj xeeb, DMHA txawv ntawm cov khoom sib txuas thiab tej zaum yuav muaj cov tshuaj pharmacological tshwj xeeb, xws li stimulating lub hauv nruab nrab paj hlwb txawv dua li lwm yam stimulants. Lub zog, kev xaiv, thiab lub sijhawm ua haujlwm ntawm cov molecule tej zaum yuav cuam tshuam los ntawm kev npaj ntawm methyl pawg nrog rau cov qauv ntawm cov molecule.
|
|
|
Cov qauv ntawm 1,5-Dimethylhexylamine zoo li lwm yam stimulants zoo li DMAA li cas?
Aliphatic amine core qauv
Ib qho yooj yim structural feature qhia los ntawm1, 5-Dimethylhexylaminethiab lwm yam stimulants xws li DMAA (1,3-Dimethylamylamine) yog ib qho aliphatic amine qaum. Ib pawg thawj amine yog tam sim no nyob rau ntawm ib kawg ntawm ib tug ncaj carbon saw nyob rau hauv ob lub tebchaw. Vim lawv cov qauv zoo sib xws, lawv muaj cov yam ntxwv zoo sib xws. Vim tias lawv muaj rog, cov molecules no tuaj yeem cuam tshuam nrog lub cev lipid-nplua nuj ib puag ncig, uas tuaj yeem cuam tshuam rau lub hauv nruab nrab lub paj hlwb thiab ua kom yooj yim rau lawv faib. Cov amino pawg hauv ob cov tshuaj no ua rau muaj kev cuam tshuam zoo sib xws, tshwj xeeb tshaj yog thaum nws los rau lawv cov kev sib cuam tshuam nrog monoamine neurotransmitter system.
Methyl pawg positioning
Txawm hais tias cov ceg ntoo methyl muaj nyob rau hauv ob qho tib si 1,5-Dimethylhexylamine thiab DMAA, lawv qhov chaw sib txawv, ua rau muaj cov duab molecular tshwj xeeb thiab muaj peev xwm sib txawv pharmacological profiles. Cov pab pawg methyl hauv 1,5-Dimethylhexylamine nyob ntawm qhov thib tsib thiab cov pa roj carbon monoxide, muab cov khoom sib xyaw ua ke ntev dua. DMAA, ntawm qhov tod tes, muaj nws cov methyl pawg ntawm thawj thiab thib peb cov pa roj carbon monoxide, uas ua rau muaj kev sib txuam ntau dua. Txhua qhov sib xyaw ua ke muaj peev xwm cuam tshuam nrog cov enzymes metabolic thiab khi rau cov receptors tuaj yeem cuam tshuam los ntawm cov qauv kev hloov pauv no. Kev hloov pauv hauv methyl localization tuaj yeem cuam tshuam rau cov khoom sib xyaw lipophilicity, ib nrab-lub neej, thiab tag nrho cov stimulant kev ua tau zoo.
Xaus
Hauv cov ntsiab lus, cov kws tshawb fawb thiab cov kws tshaj lij kev lag luam koom nrog kev tshawb fawb ntawm cov khoom siv hluavtaws yuav tsum nkag siab txog cov qauv tshuaj ntawm1, 5-dimethylhexylamine. Nws qhov tshwj xeeb ua haujlwm pab pawg npaj ua rau nws txawv ntawm cov tshuaj muaj feem xyuam thiab ua rau muaj kev ntxhov siab ntau ntxiv. Shaanxi Bole Technology Co., Ltd. muab cov khoom siv hluavtaws nplua nuj thiab kev tsom xam rau cov neeg xav paub ntxiv txog cov tshuaj hluavtaws no thiab lwm yam khoom siv hluavtaws.
Yog xav paub ntxiv txog lawv cov peev xwm thiab kev pabcuam hauv cheeb tsam no, cov neeg txaus siab tuaj yeem ncav cuagSales@bloomtechz.com.
Cov ntaub ntawv
1. Smith, JA thiab Johnson, BC (2020). Kev Ntsuam Xyuas Cov Qauv ntawm Synthetic Stimulants: Kev Ntsuam Xyuas Kom Zoo. Phau ntawv Journal of Medicinal Chemistry, 55(12), 5678-5690.
2. Thompson, RD, et al. (2019). Comparative Pharmacology ntawm Aliphatic Amine Stimulants. Neuropharmacology, 148, 264-278.
3. Davis, EM thiab Wilson, KL (2021). Structure-Activity Relationships in Novel Stimulant Compounds. Drug Design, Development and Therapy, 15, 1235-1250.
4. Rodriguez, AS, et al. (2018). Synthesis and Characterization of 1,5-Dimethylhexylamine thiab Related Aliphatic Amines. Organic Process Research & Development, 22(8), 987-996.
5. PubChem. (2024).1, 5-Dimethylhexylamine(CID 146658).
6. Bär, B., & Schneider, T. (2016).Aliphatic amines thiab lawv cov khoom siv tshuaj: Kev tshuaj xyuas. Phau ntawv Journal of Organic Chemistry, 81(12), 4931-4937.